CompaniesHaiHe Biopharma

HaiHe Biopharma

active

Shanghai, China

Founded 2011

About

Small Molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalChina

Clinical Trials (19)

Total Trials

19

As Lead Sponsor

19

As Collaborator

0

Total Enrollment

2,274

By Phase

PHASE1/PHASE2: 6PHASE2: 1PHASE1: 11PHASE2/PHASE3: 1

By Status

UNKNOWN: 6COMPLETED: 6RECRUITING: 4TERMINATED: 3

Clinical Trials Pipeline19 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

Today

Hover over trial bars to see details

Recent Trials

NCT06975618Lead Sponsor

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)

PHASE1/PHASE2Recruiting

141 participants

Started: Aug 22, 2023 · Completed: Dec 31, 2029

NCT06909877Lead Sponsor

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

PHASE1/PHASE2Recruiting

100 participants

Started: Jul 27, 2022 · Completed: Jul 30, 2027

NCT05043922Lead Sponsor

A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

86 participants

Started: Aug 13, 2021 · Completed: Jun 30, 2023

NCT04856371Lead Sponsor

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

228 participants

Started: Apr 30, 2021 · Completed: Dec 31, 2022

NCT04746612Lead Sponsor

First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors

PHASE1Terminated

22 participants

Started: Apr 8, 2021 · Completed: Mar 24, 2023

View all 19 trials →

Locations (1)

Headquarters

Shanghai, China

Map

Loading map...